рус
eng
Strategic consulting
Developing market access strategy Development of marketing strategy Portfolio assessment and development Registration dossier and market authorization
Ongoing analytical review of the Russian health care system
PharmСompass Russia PharmСompass Regions PharmCompass ЕАСU
Market research Pharmacoeconomic analysis Patient support programs
Clinical patient registries
Diabetes Mellitus Rheumatoid Arthritis (RA) Juvenile Arthritis Hemic Diseases Pituitary Tumours mRCC Diabetic Foot Syndrome Medullary Thyroid Cancer Diabetes Insipidus Other registries
Epidemiological studies Laboratory diagnostics programs Biostatistics Clinical trials Pharmacovigilance programs
BI solutions Quinta platform and Quinta solutions
Quinta Clinical Quinta Care Quinta Lab
Websites and educations web-portals Mobile apps Expert Systems
Analytical products
Aston 360 Report PharmСompass Russia Report PharmСompass Regions Report PharmCompass ЕEU
PharMon databases
PharMon Tenders PharMon Import
Expert Audit BI solutions
Press room » Aston Health news » Updated Reports PharmCompass®Russia and PharmCompass®Russian Regions
Anastasia Zhigalkina

Updated Reports PharmCompass®Russia and PharmCompass®Russian Regions

Publication date: 11 march 2021

On March 31 2021, Aston will be releasing two updated reports PharmCompass®Russia and PharmCompass®Russian Regions.

PharmCompass® Russian Regions will now be available in a new format. We have significantly improved the visual data presentation, added new information, and also made a more convenient and high-speed data upload.

To purchase the reports, please contact our project manager Veronica Vorontsova: v.vorontsova@aston-health.com

Brief description of the products:

PharmCompass®Russia was designed to help you navigate the fast-changing healthcare market and pharmaceutical landscape of Russia.

It presents a thorough analysis of federal-level regulatory frameworks in public healthcare, including:

  • Overview of the local healthcare sector at federal and regional levels
  • Relevant regulation, stakeholders mapping, public strategies and targets in healthcare
  • Comparative analysis of the healthcare funding by region, by source and type of care
  • Existing care delivery models and the recent changes
  • Pharmaceutical provision and reimbursement: programs, lists and funding

PharmCompass®Russian Regions is an analytical report presenting the key statistics and trends in healthcare in 85 regions of Russia. WEB access to the report is available via POWER BI (the cloud-based service powered by Microsoft)

The Report contains the following:

  • Overview of the Territorial Government Guarantees Programs (costs, funding by source and type of care, per capita funding rates)
  • Regional EDLs and other lists of free and discounted drugs; eligible patient categories and conditions (Gov. Resolution # 890 + orphan diseases)
  • Regional healthcare expenditure data
  • Scope and sources of pharmaceutical funding; current drug reimbursement programs adopted in the region
  • Data from regional rate agreements under OMS: DRG-based costs for hospital and day care settings, by clinic
  • Brief overview of the regional programs «Development of Healthcare»
  • Relevant socio-demographic and epidemiological characteristics, by region.
CJSC Aston Consulting, 1999-2021
General Policy on Processing of Personal Data